Pharmcos - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 49,225 | 16,153 | 8,180 | 441 | 31,438 | - | - | 1,815 |
| Profit before tax | -9,251 | -8,749 | -13,504 | -9,325 | -5,364 | -3,864 | -4,006 | -2,130 |
| Net profit | -9,251 | -8,749 | -13,504 | -9,325 | -5,364 | -3,864 | -4,006 | -2,130 |
| Equity | -235,652 | -245,966 | -259,470 | -268,795 | -274,159 | -278,023 | -282,029 | -282,013 |
| Liabilities | 343,745 | 334,134 | 316,134 | 304,819 | 295,683 | 299,547 | 303,388 | 303,389 |
| Non-current assets | 535 | 335 | 135 | 35 | 35 | 35 | 35 | 35 |
| Current assets | 107,558 | 87,833 | 56,529 | 35,989 | 21,489 | 21,489 | 21,324 | 21,341 |
| Total assets | 108,093 | 88,168 | 56,664 | 36,024 | 21,524 | 21,524 | 21,359 | 21,376 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,333 | 789 | 593 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +44.2% | -67.2% | -49.4% | -94.6% | +7028.8% | - | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -8.6% | -9.9% | -23.8% | -25.9% | -24.9% | -18.0% | -18.8% | -10.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -18.8% | -54.2% | -165.1% | -2114.5% | -17.1% | - | - | -117.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -18.8% | -54.2% | -165.1% | -2114.5% | -17.1% | - | - | -117.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 16,408 | 5,384 | 2,727 | 208 | 15,719 | - | - | 908 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Pharmcos - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-27 | 2026-03-27 | 11.58 |
| 2026-03-17 | 2026-03-24 | 11.58 |
| 2026-02-18 | 2026-02-25 | 20.22 |
| 2025-12-16 | 2025-12-28 | 27.43 |
| 2024-01-16 | 2024-01-28 | 12.09 |
| 2023-12-18 | 2023-12-27 | 1.05 |
| 2023-11-16 | 2023-11-29 | 1.04 |
| 2023-10-17 | 2023-10-29 | 1.03 |
| 2023-09-18 | 2023-09-26 | 1.02 |
| 2023-08-17 | 2023-08-24 | 1.01 |
| 2023-07-26 | 2023-07-26 | 1.00 |
| 2023-07-24 | 2023-07-25 | 1.02 |
| 2023-07-18 | 2023-07-23 | 0.02 |
| 2023-06-16 | 2023-06-27 | 0.01 |
| 2023-05-16 | 2023-05-22 | 191.74 |
| 2023-05-02 | 2023-05-03 | 145.27 |
| 2023-04-27 | 2023-04-28 | 145.27 |
| 2023-04-26 | 2023-04-26 | 168.04 |
| 2023-04-25 | 2023-04-25 | 169.33 |
| 2023-04-18 | 2023-04-24 | 168.04 |
| 2023-03-28 | 2023-03-28 | 183.11 |
| 2023-03-16 | 2023-03-27 | 205.88 |
| 2023-02-27 | 2023-03-15 | 15.07 |
| 2023-02-17 | 2023-02-26 | 27.05 |
| 2023-01-26 | 2023-01-31 | 73.87 |
| 2023-01-24 | 2023-01-25 | 73.90 |
| 2023-01-20 | 2023-01-23 | 63.48 |
| 2023-01-17 | 2023-01-19 | 63.02 |
| 2022-12-28 | 2022-12-28 | 189.49 |
| 2022-12-16 | 2022-12-27 | 226.78 |
| 2022-11-30 | 2022-12-15 | 122.03 |
| 2022-11-21 | 2022-11-29 | 144.65 |
| 2022-11-17 | 2022-11-18 | 144.65 |
| 2022-10-31 | 2022-11-02 | 120.99 |
| 2022-10-21 | 2022-10-30 | 143.61 |
| 2022-10-18 | 2022-10-20 | 144.65 |
| 2022-09-29 | 2022-09-29 | 121.36 |
| 2022-09-23 | 2022-09-28 | 143.98 |
| 2022-09-16 | 2022-09-22 | 144.65 |
| 2022-08-29 | 2022-08-29 | 122.03 |
| 2022-08-23 | 2022-08-28 | 144.65 |
| 2022-07-27 | 2022-07-27 | 121.36 |
| 2022-07-26 | 2022-07-26 | 144.44 |
| 2022-07-22 | 2022-07-25 | 143.98 |
| 2022-07-18 | 2022-07-21 | 144.65 |
| 2022-06-28 | 2022-06-28 | 139.83 |
| 2022-06-22 | 2022-06-27 | 162.45 |
| 2022-06-16 | 2022-06-21 | 167.27 |
| 2022-05-23 | 2022-05-29 | 139.44 |
| 2022-05-18 | 2022-05-22 | 144.65 |
| 2022-05-17 | 2022-05-17 | 289.30 |
| 2022-04-21 | 2022-05-16 | 144.65 |
| 2022-04-19 | 2022-04-20 | 167.27 |
| 2022-03-22 | 2022-03-28 | 35.72 |
| 2022-03-18 | 2022-03-21 | 144.65 |
| 2022-03-16 | 2022-03-17 | 167.27 |
| 2022-02-17 | 2022-02-21 | 144.50 |
| 2022-01-24 | 2022-01-24 | 29.66 |
| 2022-01-21 | 2022-01-23 | 52.43 |
| 2022-01-18 | 2022-01-20 | 148.40 |
| 2021-12-16 | 2022-01-02 | 148.40 |
| 2021-11-16 | 2021-11-30 | 209.90 |
| 2021-11-09 | 2021-11-15 | 61.50 |
| 2021-10-18 | 2021-11-08 | 1278.51 |
| 2021-10-15 | 2021-10-17 | 1217.01 |
| 2021-10-04 | 2021-10-14 | 1217.01 |
| 2021-09-02 | 2021-10-03 | 1217.01 |
Pharmcos - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.